Company Overview of Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of novel therapeutics to prevent and treat cardiovascular diseases. Its lead product candidates include CAP-1002 and Cenderitide. The company was founded in 2005 and is based in Beverly Hills, California.
8840 Wilshire Boulevard
Beverly Hills, CA 90211
Founded in 2005
Key Executives for Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|DX Biosciences, Inc.||United States|
|SerOptix, Inc.||United States|
|IDM, Inc.||United States|
|Primrose Therapeutics, Inc.||United States|
|Cogenics Icoria, Inc.||United States|
Recent Private Companies Transactions
February 3, 2015
January 9, 2015
To contact Capricor Therapeutics, Inc., please visit www.capricor.com. Company data is provided by Capital IQ. Please use this form to report any data issues.